We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+13.59%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$26.6B
AUM Growth
+$4.1B
(+18%)
Cap. Flow
+$1.26B
Cap. Flow
% of AUM
4.73%
Top 10 Holdings %
Top 10 Hldgs %
24.22%
Holding
1,386
New
198
Increased
571
Reduced
426
Closed
55
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$116M |
| 2 |
Snowflake
SNOW
|
+$77.7M |
| 3 |
Zoom
ZM
|
+$73.8M |
| 4 |
Microsoft
MSFT
|
+$63.2M |
| 5 |
TE Connectivity
TEL
|
+$62.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$61M |
| 2 |
SPLK
Splunk Inc
SPLK
|
+$57M |
| 3 |
Intuitive Surgical
ISRG
|
+$47.7M |
| 4 |
Equinix
EQIX
|
+$40.2M |
| 5 |
AT&T
T
|
+$38.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Healthcare | 16.41% |
| 3 | Financials | 11.42% |
| 4 | Communication Services | 10.26% |
| 5 | Consumer Discretionary | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Supernus Pharmaceuticals
SUPN
$2.73B
| $490K | ﹤0.01% |
19,700
| – | – |
|
1027
Erie Indemnity
ERIE
$13.4B
| $487K | ﹤0.01% |
2,021
+159
| +9% | +$37.1K |
|
1028
Envista
NVST
$4.58B
| $487K | ﹤0.01% |
+15,000
| New | +$435K |
|
1029
Inovio Pharmaceuticals
INO
$79.1M
| $478K | ﹤0.01% |
4,500
-208
| -4% | -$27.7K |
|
|
BLDP
1030
Ballard Power Systems
BLDP
$784M
| $472K | ﹤0.01% |
+21,200
| New | +$390K |
|
1031
Castle Biosciences
CSTL
$985M
| $468K | ﹤0.01% |
+7,000
| New | +$379K |
|
1032
Highwoods Properties
HIW
$3.4B
| $468K | ﹤0.01% |
12,346
+9,673
| +362% | +$349K |
|
1033
Entegris
ENTG
$23B
| $467K | ﹤0.01% |
+5,000
| New | +$437K |
|
1034
Energy Recovery
ERII
$394M
| $465K | ﹤0.01% |
+35,000
| New | +$373K |
|
1035
Nurix Therapeutics
NRIX
$2.69B
| $465K | ﹤0.01% |
+12,400
| New | +$411K |
|
1036
Autohome
ATHM
$2.65B
| $463K | ﹤0.01% |
4,790
+321
| +7% | +$31.7K |
|
1037
Dynatrace
DT
$14.4B
| $460K | ﹤0.01% |
9,752
+1,290
| +15% | +$51.2K |
|
1038
Precigen
PGEN
$2.46B
| $458K | ﹤0.01% |
46,500
-2,500
| -5% | -$16.2K |
|
1039
Tencent Music
TME
$14.3B
| $458K | ﹤0.01% |
24,001
-10,117
| -30% | -$164K |
|
1040
A10 Networks
ATEN
$1.97B
| $455K | ﹤0.01% |
47,750
-103,500
| -68% | -$813K |
|
1041
Ocular Therapeutix
OCUL
$2.14B
| $454K | ﹤0.01% |
+22,900
| New | +$340K |
|
1042
Innoviva
INVA
$1.5B
| $451K | ﹤0.01% |
37,200
-6,000
| -14% | -$64.7K |
|
1043
Myriad Genetics
MYGN
$308M
| $449K | ﹤0.01% |
24,800
-1,200
| -5% | -$19.4K |
|
1044
Aecom
ACM
$8.62B
| $447K | ﹤0.01% |
9,220
-31,942
| -78% | -$1.53M |
|
1045
WIX.com
WIX
$2.79B
| $445K | ﹤0.01% |
1,758
-612
| -26% | -$161K |
|
|
MNDT
1046
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $445K | ﹤0.01% |
20,150
-18,800
| -48% | -$290K |
|
1047
Liberty Global Class A
LBTYA
$3.48B
| $443K | ﹤0.01% |
18,174
-578
| -3% | -$12.9K |
|
|
RPTX
1048
DELISTED
Repare Therapeutics
RPTX
| $440K | ﹤0.01% |
+12,900
| New | +$385K |
|
1049
Q32 Bio
QTTB
$459M
| $436K | ﹤0.01% |
2,139
+1,389
| +185% | +$268K |
|
|
LSXMK
1050
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $432K | ﹤0.01% |
13,017
-2,519
| -16% | -$76.8K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q4 2020 Portfolio in Review
As of Q4 2020, DekaBank Deutsche Girozentrale held 1,386 positions worth $26.6B, up 18% from $22.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
DekaBank Deutsche Girozentrale deployed $1.26B of net new capital in Q4 2020, opening 198 new positions and adding to 571 existing holdings. Its largest new stake was SPX Corp: 295,000 shares worth $15.8M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alibaba, an estimated $61M trimmed.
- DekaBank Deutsche Girozentrale's largest Q4 2020 buy was SPX Corp: 295,000 shares worth $15.8M.
- DekaBank Deutsche Girozentrale added most to Abbott in Q4 2020, an estimated $116M increase.
- DekaBank Deutsche Girozentrale's biggest Q4 2020 reduction was Alibaba, cutting an estimated $61M.
- DekaBank Deutsche Girozentrale fully exited First Solar in Q4 2020, selling an estimated $5.53M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $26.6B portfolio in Q4 2020.
- DekaBank Deutsche Girozentrale opened 198 new positions and closed 55 in Q4 2020.
- DekaBank Deutsche Girozentrale's portfolio value rose 18% quarter-over-quarter to $26.6B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2020, filed 12 Mar 2021.